Study of Oral Dehydroepiandrosterone(DHEA) to Treat Previously Unexplained Infertility (NCT00650754) | Clinical Trial Compass
TerminatedPhase 2/3
Study of Oral Dehydroepiandrosterone(DHEA) to Treat Previously Unexplained Infertility
Stopped: Failure to recruit designed nuimebrt of subjects
United States35 participantsStarted 2008-03
Plain-language summary
The experimental focus of this project is on the interaction of DHEA treatment on pregnancy in women with otherwise unexplained infertility and evidence of premature ovarian aging (POA).
Who can participate
Age range21 Years – 37 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* \>= 1 year of infertility
* \< 38 years old
* Normal HSG
* Normal Semen analysis (Count \>= 20 million/ motility \> 50%/ Kruger morph \> 14%.
* Regular menses
* Willingness to sign informed consent for study randomization
* Willingness to participate in 8 months of non-IVF will he him treatment.
Exclusion Criteria:
* Abnormal semen analysis
* Abnormal HSG
* Baseline FSH/E2 within normal age specific criteria
* Medical condition that would contraindicate pregnancy, ovulation induction or general anesthesia
* Family history of significant genetic disease, or factor V leiden thrombophilia
* Inability to present for monitoring visits
* Inability to follow medication instruction
* Desire to undergo other fertility treatments before completing eight months of this trial